FindTrial
Sign In

Autoimmunity in Retinitis Pigmentosa

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00433277
Enrollment
Unknown
Registered
2007-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2007-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis Pigmentosa

Brief summary

Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.

Interventions

DRUGtwice-daily dosage with 0.5% cyclosporine-A eyedrops

Sponsors

Semmelweis University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Clinical diagnosis of retinitis pigmentosa

Exclusion criteria

* Cataract * Extremely low ERG wave amplitude (less than 8% of normal)

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026